Ads
-
Related paper
- Formulation and Characterization of Repaglinide Chitosan Nanoparticles for the Treatment of Diabetes Mellitus Type II
- Oxidizing modification of albumens in plasma of blood of patients by diabetes mellitus of type 2 iin dependence on degree of indemnification of carbohydrate exchange and duration of diabetes mellitus of type 2
- THE CYTOPROTECTIVE EFFECT OF INTERLEUKIN 4 ON FIBROBLASTS COCULTERED WITH THE MONONUCLEARS OF PATIENTS WITH TYPE 2 DIABETES MELLITUS AND THOSE WITH TYPE 2 DIABETES MELLITUS AND CHRONIC FOOT ULCERS IN A 3D CULTURE MODEL
- Effects of Pedometer Based Walking Program on Diabetes Treatment Satisfaction Scores in Patients with Type 2 Diabetes Mellitus
- Use of Complementary Alternative Medicines by the Malaysians for the Treatment of Type 1 and Type 2 Diabetes Mellitus: A Cross-Sectional Study
- Risk and Benefits of Canagliflozin, a New Sodium-Glucose Co-Transporter Type 2 Inhibitor, in the Treatment of type-2 Diabetes Mellitus
- FORMULATION AND IN-VITRO CHARACTERIZATION OF LOSARTAN POTASSIUM AND REPAGLINIDE BILAYER TABLETS
- Formulation and Characterization of Macitantan Nanoparticles for the Treatment of Pulmonary Hypertension
- Characterization and Antitumor Activity of Chitosan/Poly (Vinyl Alcohol) Blend Doped with Gold and Silver Nanoparticles in Treatment of Prostatic Cancer Model
- Characterization of Heart wall Diseases in Patients with Type-2 Diabetes Mellitus using Echocardiography
